Study on PAD and CAS Based on Omics and Imaging

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorYijie Ning

About this trial

This study aims to investigate the pathogenesis of Peripheral Artery Disease (PAD) and Carotid Artery Stenosis (CAS) using a comprehensive multi-omics and multi-modal imaging approach. The study will enroll patients diagnosed with PAD or CAS and perform advanced imaging techniques, including NIR-II Imaging, DUS-based V-flow Imaging, and Laser Speckle Imaging, to assess vascular structure and function. Simultaneously, single-cell transcriptomics, metabolomics, lipidomics, and proteomics analyses will be conducted on patient samples to identify key molecular targets and pathways involved in disease progression. Machine learning algorithms will be employed to integrate imaging and multi-omics data, enabling the development of predictive models for more accurate disease diagnosis and stratification. The findings from this study are expected to provide novel insights into the molecular mechanisms underlying PAD and CAS and contribute to the development of personalized therapeutic strategies.

Eligibility criteria

Qualifiers

The study subjects are inpatients from the Department of Vascular Surgery at the Second Hospital of Shanxi Medical University.

Males or females aged between 18 and 85 years.

Diagnosed with Peripheral Artery Disease (PAD) or Carotid Artery Stenosis (CAS).

Participants are conscious, fully informed about the study content, and have signed the informed consent form, agreeing to participate in this study.

Disqualifiers

Non-atherosclerotic stenosis (e.g., vasculitis or dissection).

PAD patients who have previously undergone interventional treatments (e.g., balloon angioplasty or stent placement) and/or surgical procedures.

Patients with heart failure classified as NYHA Class II-IV or those with a history of coronary artery disease.

Patients with acute infections, tumors, severe arrhythmias, psychiatric disorders, or drug/alcohol addiction.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Yijie Ning

Lead sponsor

Second Hospital of Shanxi Medical University

Sponsor institution